S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
pixel
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
pixel
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
pixel
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
pixel
pixel
Log in
ASX:BGT

Bio-Gene Technology Limited (BGT.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.19
MA: A$0.19
A$0.19
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bio-Gene Technology Limited, a biotechnology company, engages in developing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. It is involved in developing Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from the leaves of rare eucalyptus trees. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has collaborations with Pacific Discovery Services for studying Flavocide's mode of action; and the Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.

MarketRank

Overall MarketRank

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 3 9628 4178
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$122,795.00
Book ValueA$0.04 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive BGT News and Ratings via Email

Sign-up to receive the latest news and ratings for BGT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Bio-Gene Technology Limited (BGT.AX) (ASX:BGT) Frequently Asked Questions

What stocks does MarketBeat like better than Bio-Gene Technology Limited (BGT.AX)?

Wall Street analysts have given Bio-Gene Technology Limited (BGT.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Bio-Gene Technology Limited (BGT.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Bio-Gene Technology Limited (BGT.AX)'s key competitors?

Who are Bio-Gene Technology Limited (BGT.AX)'s key executives?

Bio-Gene Technology Limited (BGT.AX)'s management team includes the following people:
  • Mr. Richard Jagger B.Sc., BSC (HONS), M.INTL.BUS, GAICD, MD, CEO & Director
  • Mr. Roger McPherson C.P.A., CPA, B.Bus, GAICD, CFO & Company Sec.
  • Mr. Peter Donald May AFAIM, M.B.A., MBA, AFA1M, GAICD, Exec. Director of R&D and Exec. Director

What is Bio-Gene Technology Limited (BGT.AX)'s stock symbol?

Bio-Gene Technology Limited (BGT.AX) trades on the ASX under the ticker symbol "BGT."

How big of a company is Bio-Gene Technology Limited (BGT.AX)?

Bio-Gene Technology Limited (BGT.AX) has a market capitalization of $0.00 and generates $122,795.00 in revenue each year.

What is Bio-Gene Technology Limited (BGT.AX)'s official website?

The official website for Bio-Gene Technology Limited (BGT.AX) is www.bio-gene.com.au.

How can I contact Bio-Gene Technology Limited (BGT.AX)?

The company can be reached via phone at 61 3 9628 4178.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.